Targeting CD19-Negative Relapsed B-Acute Lymphoblastic Leukemia Using Trivalent CAR T Cells

被引：0

作者：

Fousek, Kristen ^{[1
]}

Watanabe, Junji ^{[2
]}

George, Ann ^{[2
]}

Byrd, Tiara ^{[1
]}

An, Xingyue ^{[3
]}

Samaha, Hebatalla ^{[1
]}

Salsman, Vita ^{[1
]}

Navai, Shoba ^{[1
]}

Jang, Albert ^{[1
]}

Kim, Hye Na ^{[2
]}

Joseph, Sujith ^{[1
]}

Baker, Matthew ^{[1
]}

Varadarajan, Navin ^{[3
]}

Hegde, Meenakshi ^{[1
]}

Kim, Yong-Mi ^{[2
]}

Heisterkamp, Nora ^{[2
]}

Abdel-Azim, Hisham ^{[2
]}

Ahmed, Nabil ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA

[3] Univ Houston, Houston, TX USA

来源：

MOLECULAR THERAPY | 2018年 / 26卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

647

引用

页码：298 / 298

页数：1

共 50 条

[1] Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells.
Fousek, Kristen
Watanabe, Junji
George, Ann
An, Xingyue
Samaha, Heba Samir
Navai, Shoba Alaska
Byrd, Tiara T.
Jang, Albert
Kim, Hye Na
Joseph, Sujith
Baker, Matthew
Varadarajan, Navin
Hegde, Meenakshi G.
Kim, Yong-Mi
Heisterkamp, Nora
Abdel-Azim, Hisham M.
Ahmed, Nabil M.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
[2] Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells
Fousek, Kristen
Watanabe, Junji
George, Ann
An, Xingyue
Samaha, Hebatalla
Navai, Shoba Alaska
Byrd, Tiara T.
Jang, Albert
Kim, Hye Na
Joseph, Sujith
Baker, Matthew
Varadarajan, Navin
Hegde, Meenakshi G.
Kim, Yong-Mi
Heisterkamp, Nora
Abdel-Azim, Hisham
Ahmed, Nabil
BLOOD, 2017, 130
[3] Trivalent CAR T cells mitigate CD19-negative relapse and improve tumor control in primary pre-B cell acute lymphoblastic leukemia (B-ALL)
Fousek, Kristen
Watanabe, Junji
An, Xingyue
George, Ann
Samaha, Heba
Navai, Shoba
Byrd, Tiara T.
Kirzner, Jonathan
Kim, Hye Na
Jang, Albert
Joseph, Sujith
Baker, Matthew
Hegde, Meenakshi
Varadarajan, Navin
Heisterkamp, Nora
Abdel-Azim, Hisham
Ahmed, Nabil
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
[4] Cannibalism in Relapsed B-acute Lymphoblastic Leukemia
P. S. Shobhanaa
Naveen Kakkar
Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 544 - 545
[5] Cannibalism in Relapsed B-acute Lymphoblastic Leukemia
Shobhanaa, P. S.
Kakkar, Naveen
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (03) : 544 - 545
[6] CD19-negative B-lineage acute lymphoblastic leukemia: A diagnostic and therapeutic challenge
Bansal, Shashi
Sharma, Upendra
Jain, Akansha
Sharma, Richa
Yagnik, Bhargav
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (04) : 596 - 598
[7] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Curran, Kevin
PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
[8] Anti-CD19 CAR T-cell therapy post antibody treatment in adult patients with relapsed/refractory precursor B-acute lymphoblastic leukemia
Danylesko, Ivetta
Besser, Michal
Jacoby, Elad
Itzhaki, Orit
Shem-Tov, Noga
Yerushalmi, Ronit
Toren, Amos
Shimoni, Avichai
Nagler, Arnon
Avigdor, Abraham
BONE MARROW TRANSPLANTATION, 2019, 54 : 517 - 518
[9] Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Hanren Dai
Zhiqiang Wu
Hejin Jia
Chuan Tong
Yelei Guo
Dongdong Ti
Xiao Han
Yang Liu
Wenying Zhang
Chunmeng Wang
Yajing Zhang
Meixia Chen
Qingming Yang
Yao Wang
Weidong Han
Journal of Hematology & Oncology, 13
[10] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Davila, Marco L.
Brentjens, Renier J.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808

← 1 2 3 4 5 →